PropertyValue
?:abstract
  • Coronavirus disease 2019 (COVID-19), first recognized in Wuhan, China, was recently declared a global pandemic by the World Health Organization (WHO). Advanced age and comorbid disease, well-known characteristics in the solid tumor population, have been reported as risk factors for severe disease and death. Cancer-related immunosuppression and its treatments also seem to play an active role in the prognosis, response, and clinical outcomes of these patients. The most effective combination therapy for COVID-19 is still under investigation, and the use of corticosteroids is controversial. Although, as a group, metastatic cancer patients are often considered not to be good candidates for ICU treatment, the individual prognosis should always come into consideration, even in a context of high pressure on medical facilities. We report the case of a stage IV prostate cancer patient infected with SARS-CoV-2 who required ICU admission and recovered from COVID-19 infection. Further studies are needed in order to identify accurate clinical prognostic criteria and provide the best treatment for these challenging patients.
is ?:annotates of
?:creator
?:doi
  • 10.4322/acr.2020.179
?:doi
?:journal
  • Autopsy_&_case_reports
?:license
  • cc-by-nc
?:pdf_json_files
  • document_parses/pdf_json/b308a811b3f31b3d22a1c1b174f6e1f30771baae.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7703164.xml.json
?:pmcid
?:pmid
?:pmid
  • 33344300.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Full recovery of a stage IV cancer patient facing COVID-19 pandemic
?:type
?:year
  • 2020-06-05

Metadata

Anon_0  
expand all